Time | Study Group | Control Group | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
BC | BC + NRT | BC + Bupropion | BC + Varenicline | P Value | BC | BC + NRT | BC + Bupropion | BC + Varenicline | P Value | |
First week | 9 (50) | 14 (50) | 12 (46.1) | 16 (55.1) | .231 | 17 (65.3) | 18 (56.2) | 20 (62.5) | 19 (51.3) | .125 |
Second week to first month | 6 (33.3) | 8 (32) | 6 (23) | 7 (24.1) | .158 | 6 (18.7) | 7 (21.8) | 6 (18.7) | 10 (27) | .098 |
First to third month | 2 (11.1) | 1 (4) | 6 (23) | 3 (10.3) | .02 | 2 (6.2) | 4 (12.5) | 4 (12.5) | 5 (13.5) | .03 |
Third to sixth month | 1 (5.5) | 2 (8) | 2 (7.6) | 3 (10.3) | .568 | 1 (3.1) | 3 (9.3) | 2 (6.2) | 3 (8.1) | .215 |
Total relapse rate | 18 (62) | 25 (53.1) | 26 (57.7) | 29 (53.7) | .012 | 26 (83.8) | 32 (76.1) | 32 (69.5) | 37 (66) | .009 |
BC, behavioral counseling (motivational interview with life style modification); NRT, nicotine replacement therapy.